carbostyril has been researched along with Aspergillosis, Allergic Bronchopulmonary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, S; Christiansen, N; Gomez-Pastrana, D; McLean, M; Nwokoro, C; Pao, CS | 1 |
| Davies, JC | 1 |
2 other study(ies) available for carbostyril and Aspergillosis, Allergic Bronchopulmonary
| Article | Year |
|---|---|
[Real-world effectiveness of ivacaftor in children with cystic fibrosis and the G551D mutation].
Topics: Adolescent; Aminophenols; Aspergillosis, Allergic Bronchopulmonary; Child; Chloride Channel Agonists; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Female; Genotype; Humans; Male; Mutation; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Nutritional Status; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Treatment Outcome | 2019 |
Cystic fibrosis in 2016: considerable progress, but much more to do.
Topics: Aminophenols; Aspergillosis, Allergic Bronchopulmonary; Chloride Channel Agonists; Comorbidity; Cystic Fibrosis; Humans; Pseudomonas Infections; Quinolones | 2016 |